These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21698186)

  • 1. Disruption of LRRK2 does not cause specific loss of dopaminergic neurons in zebrafish.
    Ren G; Xin S; Li S; Zhong H; Lin S
    PLoS One; 2011; 6(6):e20630. PubMed ID: 21698186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defect.
    Sheng D; Qu D; Kwok KH; Ng SS; Lim AY; Aw SS; Lee CW; Sung WK; Tan EK; Lufkin T; Jesuthasan S; Sinnakaruppan M; Liu J
    PLoS Genet; 2010 Apr; 6(4):e1000914. PubMed ID: 20421934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 knockdown in zebrafish causes developmental defects, neuronal loss, and synuclein aggregation.
    Prabhudesai S; Bensabeur FZ; Abdullah R; Basak I; Baez S; Alves G; Holtzman NG; Larsen JP; Møller SG
    J Neurosci Res; 2016 Aug; 94(8):717-35. PubMed ID: 27265751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomical localization of leucine-rich repeat kinase 2 in mouse brain.
    Melrose H; Lincoln S; Tyndall G; Dickson D; Farrer M
    Neuroscience; 2006; 139(3):791-4. PubMed ID: 16504409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra.
    Han BS; Iacovitti L; Katano T; Hattori N; Seol W; Kim KS
    Neurosci Lett; 2008 Sep; 442(3):190-4. PubMed ID: 18634852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4.
    Häbig K; Gellhaar S; Heim B; Djuric V; Giesert F; Wurst W; Walter C; Hentrich T; Riess O; Bonin M
    Biochim Biophys Acta; 2013 Dec; 1832(12):2352-67. PubMed ID: 24075941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.
    Yao C; El Khoury R; Wang W; Byrd TA; Pehek EA; Thacker C; Zhu X; Smith MA; Wilson-Delfosse AL; Chen SG
    Neurobiol Dis; 2010 Oct; 40(1):73-81. PubMed ID: 20382224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of lrrk2 causes early developmental abnormalities and age-dependent increase of monoamine catabolism in the zebrafish brain.
    Suzzi S; Ahrendt R; Hans S; Semenova SA; Chekuru A; Wirsching P; Kroehne V; Bilican S; Sayed S; Winkler S; Spieß S; Machate A; Kaslin J; Panula P; Brand M
    PLoS Genet; 2021 Sep; 17(9):e1009794. PubMed ID: 34516550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A QUICK screen for Lrrk2 interaction partners--leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics.
    Meixner A; Boldt K; Van Troys M; Askenazi M; Gloeckner CJ; Bauer M; Marto JA; Ampe C; Kinkl N; Ueffing M
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.001172. PubMed ID: 20876399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucine-rich repeat kinase 2 is associated with the endoplasmic reticulum in dopaminergic neurons and accumulates in the core of Lewy bodies in Parkinson disease.
    Vitte J; Traver S; Maués De Paula A; Lesage S; Rovelli G; Corti O; Duyckaerts C; Brice A
    J Neuropathol Exp Neurol; 2010 Sep; 69(9):959-72. PubMed ID: 20720502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of LRRK2 in Zebrafish leads to hyperactivity and weakened antibacterial response.
    Sheng D; See K; Hu X; Yu D; Wang Y; Liu Q; Li F; Lu M; Zhao J; Liu J
    Biochem Biophys Res Commun; 2018 Mar; 497(4):1104-1109. PubMed ID: 29499195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression.
    Reinhardt P; Schmid B; Burbulla LF; Schöndorf DC; Wagner L; Glatza M; Höing S; Hargus G; Heck SA; Dhingra A; Wu G; Müller S; Brockmann K; Kluba T; Maisel M; Krüger R; Berg D; Tsytsyura Y; Thiel CS; Psathaki OE; Klingauf J; Kuhlmann T; Klewin M; Müller H; Gasser T; Schöler HR; Sterneckert J
    Cell Stem Cell; 2013 Mar; 12(3):354-67. PubMed ID: 23472874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 localizes to endosomes and interacts with clathrin-light chains to limit Rac1 activation.
    Schreij AM; Chaineau M; Ruan W; Lin S; Barker PA; Fon EA; McPherson PS
    EMBO Rep; 2015 Jan; 16(1):79-86. PubMed ID: 25427558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of LRRK2/PARK8 induces degeneration of dopaminergic neurons in Drosophila.
    Lee SB; Kim W; Lee S; Chung J
    Biochem Biophys Res Commun; 2007 Jun; 358(2):534-9. PubMed ID: 17498648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain.
    Higashi S; Moore DJ; Colebrooke RE; Biskup S; Dawson VL; Arai H; Dawson TM; Emson PC
    J Neurochem; 2007 Jan; 100(2):368-81. PubMed ID: 17101029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans.
    Saha S; Guillily MD; Ferree A; Lanceta J; Chan D; Ghosh J; Hsu CH; Segal L; Raghavan K; Matsumoto K; Hisamoto N; Kuwahara T; Iwatsubo T; Moore L; Goldstein L; Cookson M; Wolozin B
    J Neurosci; 2009 Jul; 29(29):9210-8. PubMed ID: 19625511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake.
    Zhou H; Huang C; Tong J; Hong WC; Liu YJ; Xia XG
    Int J Biol Sci; 2011; 7(6):753-61. PubMed ID: 21698001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.
    Melrose HL; Dächsel JC; Behrouz B; Lincoln SJ; Yue M; Hinkle KM; Kent CB; Korvatska E; Taylor JP; Witten L; Liang YQ; Beevers JE; Boules M; Dugger BN; Serna VA; Gaukhman A; Yu X; Castanedes-Casey M; Braithwaite AT; Ogholikhan S; Yu N; Bass D; Tyndall G; Schellenberg GD; Dickson DW; Janus C; Farrer MJ
    Neurobiol Dis; 2010 Dec; 40(3):503-17. PubMed ID: 20659558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice.
    Yue M; Hinkle KM; Davies P; Trushina E; Fiesel FC; Christenson TA; Schroeder AS; Zhang L; Bowles E; Behrouz B; Lincoln SJ; Beevers JE; Milnerwood AJ; Kurti A; McLean PJ; Fryer JD; Springer W; Dickson DW; Farrer MJ; Melrose HL
    Neurobiol Dis; 2015 Jun; 78():172-95. PubMed ID: 25836420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player.
    Häbig K; Walter M; Poths S; Riess O; Bonin M
    Neurogenetics; 2008 May; 9(2):83-94. PubMed ID: 18097693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.